111 related articles for article (PubMed ID: 520501)
1. Two novel prolactin release-inhibiting 8 alpha-amino-ergolines.
Flückiger E; Briner U; Bürki HR; Marbach P; Wagner HR; Doepfner W
Experientia; 1979 Dec; 35(12):1677-8. PubMed ID: 520501
[TBL] [Abstract][Full Text] [Related]
2. Prolactin secretion inhibition by a new 8alpha-amino-ergoline, CH 29-171.
Flückiger E; Briner U; Doepfner W; Kovacs E; Marbach P; Wagner HR
Experientia; 1978 Oct; 34(10):1330-2. PubMed ID: 570121
[No Abstract] [Full Text] [Related]
3. Dopamine agonistic potency of two novel prolactin release-inhibiting ergolines.
Markó M
Eur J Pharmacol; 1984 Jun; 101(3-4):263-6. PubMed ID: 6468500
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic profile of CQP 201-403, a novel 8 alpha-amino-ergoline.
Flückiger E; Briner U; Clark B; Closse A; Enz A; Gull P; Hofmann A; Markstein R; Tolcsvai L; Wagner HR
Experientia; 1988 May; 44(5):431-6. PubMed ID: 3371446
[TBL] [Abstract][Full Text] [Related]
5. Biphasic influence of a 8 alpha-amino ergoline, CU 32-085, on striatal dopamine synthesis and turnover in vivo in the rat.
Enz A
Life Sci; 1981 Nov; 29(21):2227-34. PubMed ID: 6119592
[No Abstract] [Full Text] [Related]
6. Substituted 5-amino-4,5,6,7-tetrahydroindazoles as partial ergoline structures with dopaminergic activity.
McQuaid LA; Latz JE; Clemens JA; Fuller RW; Wong DT; Mason NR
J Med Chem; 1989 Oct; 32(10):2388-96. PubMed ID: 2571732
[TBL] [Abstract][Full Text] [Related]
7. Interaction of sulfpride and ergot derivatives on rat brain DOPAC concentration and prolactin secretion in vivo.
Hofmann M; Battaini F; Tonon G; Trabucchi M; Spano P
Eur J Pharmacol; 1979 Jun; 56(1-2):15-20. PubMed ID: 467503
[TBL] [Abstract][Full Text] [Related]
8. Interaction of metergoline with striatal dopamine system.
Spano PF; Biggio G; Casu M; Gessa GL; Bareggi SR; Govoni S; Trabucchi M
Life Sci; 1978 Dec; 23(24):2383-91. PubMed ID: 745518
[No Abstract] [Full Text] [Related]
9. Effect of ergoline derivative VUFB-6638 on the adenohypophysial prolactin concentration in rats.
Krejcí P; Ausková M; Rezábek K; Bílek J; Semonský M
Endocrinol Exp; 1975 Jan; 9(1):68-72. PubMed ID: 6259
[TBL] [Abstract][Full Text] [Related]
10. Changes in the concentration of adenohypophyseal prolactin and morphological manifestations in the adenohypophysis of lactating rats after administration of D-6-methyl-8-[beta-isopropylaminoethyl] ergoline-I.
Krejcí P; Marhan O; Ausková M; Rezábek K; Semonský M
Experientia; 1976 Oct; 32(10):1308-9. PubMed ID: 987925
[TBL] [Abstract][Full Text] [Related]
11. Ergoline congeners as potential inhibitors of prolactin release. 2.
Rusterholz DB; Barfknecht CF; Clemens JA
J Med Chem; 1976 Jan; 19(1):99-102. PubMed ID: 1246056
[TBL] [Abstract][Full Text] [Related]
12. Nidation inhibition by simple ergoline derivatives.
Rezábek K; Cassady JM; Floss HG
J Pharm Sci; 1975 Jun; 64(6):1045-6. PubMed ID: 1133727
[TBL] [Abstract][Full Text] [Related]
13. Ergolines as potential prolactin and mammary tumor inhibitors.
Cassady JM; Floss HG
Lloydia; 1977; 40(1):90-106. PubMed ID: 327183
[No Abstract] [Full Text] [Related]
14. Influence of ergot alkaloids on pituitary prolactin and prolactin-dependent processes.
Floss HG; Cassady JM; Robbers JE
J Pharm Sci; 1973 May; 62(5):699-715. PubMed ID: 4574586
[No Abstract] [Full Text] [Related]
15. Mechanisms of dihydroergotoxine's effect on prolactin release.
Hofmann M; Tonon GC; Spano PF; Trabucchi M
J Pharm Pharmacol; 1979 Jan; 31(1):42-4. PubMed ID: 32366
[No Abstract] [Full Text] [Related]
16. Activation of accumbal and striatal dopamine autoreceptors by some ergoline derivatives.
Gundlach AL; Christie MJ; Beart PM
Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):149-52. PubMed ID: 3992029
[TBL] [Abstract][Full Text] [Related]
17. Effects of ergocryptine on prolactin secretion druing concurrent pregnancy and lactation in the rat.
Flint DJ; Ensor DM
J Reprod Fertil; 1979 Jul; 56(2):691-6. PubMed ID: 582608
[TBL] [Abstract][Full Text] [Related]
18. Correlation between inhibitory effect on prolactin secretion and antitumor activity of new ergoline compounds on DMBA-induced tumors in rats.
Formelli F; Zaccheo T; Di Salle E; Ornati G; Di Marco A
Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1545-51. PubMed ID: 6416848
[TBL] [Abstract][Full Text] [Related]
19. Altered behavioral response to a D2 agonist, LY141865, in spontaneously hypertensive rats exhibiting biochemical and endocrine responses similar to those in normotensive rats.
Fuller RW; Hemrick-Luecke SK; Wong DT; Pearson D; Threlkeld PG; Hynes MD
J Pharmacol Exp Ther; 1983 Nov; 227(2):354-9. PubMed ID: 6138425
[TBL] [Abstract][Full Text] [Related]
20. The D-2 agonist quinpirole releases striatal dopamine in vivo.
Sharp T; Zetterström T; Collin AK; Ungerstedt U
Eur J Pharmacol; 1987 Oct; 142(1):187-8. PubMed ID: 2961580
[No Abstract] [Full Text] [Related]
[Next] [New Search]
